MedTrace Logo

Ultrasound Targeting for the Lumpectomy Cavity

NCT00583843 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2014-01-16

No results posted yet for this study

Summary

Accurate targeting of treatment sites should increase local control by radiation therapy for breast-cancer lumpectomy patients. Currently, ultrasound localization is used for prostate cancer patients to locate the prostate before daily radiation treatments. There is now documented evidence that the lumpectomy site does change during the external radiation therapy. Thus, treatment efficacy should be increased by localizing the target, monitoring volume changes, and adjusting the radiation target prior to the boost radiation dose.

Conditions

  • Breast Neoplasms

Interventions

PROCEDURE

Ultrasound

Ultrasound weekly during initial fields of radiation, and daily during the boost phase.

Sponsors & Collaborators

  • University of Iowa

    lead OTHER

Principal Investigators

  • Geraldine Jacobson, MD MPH · The Department of Radiation Oncology

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-06-30
Primary Completion
2009-04-30
Completion
2011-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00583843 on ClinicalTrials.gov